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carrying one or two copies of the G allele was associated with 13% higher
grade – corresponding to lower disc signal intensity – than that of AA
homozygotes (adjustment as before, p< 0.02). The SNP detected maps
to chromosome 15q22 and a gene of as yet unknown function. Of interest,
this gene has been shown in human tissue microarray experiments to be
up-regulated in bone from non-healing versus normal healing fracture,
pointing to a role in bone formation and/or remodeling. Furthermore,
we went on to test this SNP for association with spine bone mineral
density (BMD). In the TwinsUK cohort the genotype was signiﬁcantly
associated with spine BMD (after adjustment, p< 0.002). A similar trend
was observed among women from the Chingford cohort (p< 0.06) but
only among women who did not report back pain.
Conclusions: These results from two independent population based
cohorts of women point to a novel genetic variant involved in the sus-
ceptibility to LDD. It is possible that this variant acts to promote LDD
through altering local bone metabolism.
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Purpose: The Wnt-beta-catenin signaling pathway is a powerful stim-
ulator of chondrocyte matrix catabolic action and may have a role in
excessive remodeling and degradation of cartilage matrix in osteoarthritis
(OA). The ANP32A gene encodes a tumor suppressor molecule – pp32 –
involved in ERK signaling and shown to inhibit canonical Wnt signaling
via its interaction with Axin1. Wnt5a is a mediator of non-canonical Wnt
signaling, involved in inﬂammation, angiogenesis and down-regulation
of the canonical Wnt pathway. We tested whether variation at genes
encoding these two Wnt signaling molecules was associated with OA
of the hip or the knee in women in 2479 women from the UK and
1987 women from the Netherlands.
Methods: Two SNPs in the WNT5A gene and 8 SNPs in the ANP32A
gene were genotyped in 435 controls, 643 knee OA cases and 571 hip
OA female cases from Nottingham (UK). Results were replicated in a
population based cohort, the Chingford study of 830 women. The top
SNP from the ANP32A gene was also replicated in women from the
Rotterdam study (131 total hip replacement cases and 1856 controls).
Results: Five SNPs in the ANP32A gene and both of the WNT5A
SNPS were signiﬁcantly associated with hip OA in the Nottingham cases
(p< 0.009 and p< 0.002 best p-values respectively) but not knee OA.
The Wnt5A SNPs were not associated with knee OA in the Chingford
cohort but had p-values of p< 0.02 and p< 0.08 for hip OA. Combining
Chingford and Nottingham data resulted in a Mantel-Haenszel odds ratio
of 1.49 (95% CI 1.18−1.88; p< 8×10−4) for the minor allele of rs648872
and an ORMH =0.79 (95% CI 0.66−0.94; p< 0.009) for the minor allele of
rs1047898. Of the ﬁve ANP32A SNPs signiﬁcant in the Nottingham hip
OA cases, two were also associated with hip OA (rs7164503 p< 0.016
and rs1551343 p< 0.049) and rs7164503 also with knee OA (p< 0.048) in
the Chingford study. A meta-analysis of hip OA incorporating data of the
Rotterdam cohort yielded an ORMH =0.69 (95% CI 0.54−0.90; p< 0.0033)
for the minor allele of rs7164503. The ANP32A transcript was found to
be abundantly expressed in articular cartilage from OA patients and the
minor allele at rs7164503 was associated with signiﬁcantly lower cis-
acting allelic expression levels of the ANP32A transcript in lymphoblast
cell lines.
Conclusions: Our results demonstrate two novel gene loci are associ-
ated with OA and provide further evidence that Wnt-beta-catenin signaling
molecules are involved in the pathogenesis of cartilage related diseases.
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